Skip to content
AstraZeneca PLC

AstraZeneca PLC technical analysis

AZN.STHealthcare Updated daily

Technical analysis of AstraZeneca PLC (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is AstraZeneca PLC

AstraZeneca PLC is a biopharmaceutical company engaged in the discovery, development, manufacture, and commercialization of prescription medicines. The company offers a portfolio of drugs across multiple therapeutic areas including oncology, cardiovascular diseases, renal and metabolic disorders, respiratory and immunology conditions, vaccines, and rare disease therapies. Its products are distributed through representatives and distributors in the United Kingdom, the Americas, Europe, Asia, Africa, and Australasia.

Description generated automatically from public sources; it may be inaccurate or out of date.

AstraZeneca PLC: latest session data

Closing values for September 4, 2026, computed on the last 12 months of prices.

Close1,555.50 SEK
Change−0.96%
RSI (14)46.7
MACD-8.823
ADX20.6
Volatility (ATR)2.44%
Volume vs 20-avg97%
12-month high1,912.69 SEK
12-month low1,457.24 SEK

Moving averages

21 sessions

1,547.69 SEK

+0.50%

50 sessions

1,619.53 SEK

−3.95%

200 sessions

1,703.19 SEK

−8.67%

Session levels

s2

1,536.50

Support

s1

1,553.50

Support

pivot

1,570.50

Pivot

r1

1,587.50

Resistance

r2

1,604.50

Resistance

How to read it

In the September 4, 2026 session AstraZeneca PLC closed lower at 1,555.50 SEK, −0.96% versus the previous session.

The price sits mixed against its moving averages: +0.50% against the 21-session average, −3.95% against the 50 and −8.67% against the 200.

The 14-period RSI reads 46.7, in neutral territory.

MACD stands at -8.823 against a signal line at -14.463: the histogram is positive (+5.640).

ADX reads 20.6, indicating weak directionality.

Levels computed on the latest session place supports at 1,553.50 and 1,536.50 SEK and resistances at 1,587.50 and 1,604.50 SEK, around a pivot of 1,570.50.

The average daily range (ATR) is 37.905 SEK, or 2.44% of price.

Turnover was 541.5K shares, 97% of the 20-session average.

Over the last twelve months the price ranged between 1,457.24 and 1,912.69 SEK, and today stands −18.67% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of AstraZeneca PLC

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the AZN.ST analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about AstraZeneca PLC

How is AstraZeneca PLC analysed technically?

Technical analysis of AstraZeneca PLC is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for AstraZeneca PLC?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to AstraZeneca PLC?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to AstraZeneca PLC it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.